Q&A Session #2

Julien Seneschal, MD, PHD

Vitiligo: Looking at the Memory T Cell Response

Jesslyn Alyce Magee, MS

Pilot Network Model for Automated Vitiligo Lesion Segmentation: Promise and Challenges

Nanja van Geel, MD, PhD – Oral Abstract

Influencing Factors on the Patient Global Assessment Score for Vitiligo Severity

Pearl Grimes, MD

Effects of Ruxolitinib Cream on Affected Body Areas in Patients with Vitiligo: Subgroup Analysis from a 52-Week, Randomized, Double-Blind Trial

John E. Harris, MD, PhD

Advances In Immune Mechanisms Of Vitiligo

Q&A Session #1

Chris O’Brien

Patient Stories, Data and Demo – MyVitiligoTeam
(Patient Social Network)

Vidhya Shankar Narayan, MD

Donor to Recipient Ratios in the Surgical Treatment of Vitiligo and Piebaldism: A Systematic Review

Jung Min Bae, MD, PhD

Vitiligo and Comorbidity: A Comprehensive Review